Virginia (State or other jurisdiction of incorporation) | 1-9819 (Commission File Number) | 52-1549373 (IRS Employer Identification No.) | |
4991 Lake Brook Drive, Suite 100 Glen Allen, Virginia (Address of principal executive offices) | 23060-9245 (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit No. | Description | |
99.1 | Press Release dated February 15, 2017 |
DYNEX CAPITAL, INC. | |||
Date: | February 15, 2017 | By: | /s/ Stephen J. Benedetti |
Stephen J. Benedetti | |||
Executive Vice President, Chief Financial Officer and Chief Operating Officer |
FOR IMMEDIATE RELEASE | CONTACT: | Alison Griffin | |
February 15, 2017 | (804) 217-5897 |
• | Comprehensive loss of $(0.37) per common share comprised of net income to common shareholders of $1.36 per common share and other comprehensive loss of $(1.73) per common share |
• | Core net operating income, a non-GAAP measure, of $0.20 per common share |
• | Net interest spread of 1.84% and adjusted net interest spread, a non-GAAP measure, of 1.81% |
• | Book value per common share of $7.18 at December 31, 2016, a decrease of $(0.58) from September 30, 2016 book value per common share of $7.76 |
• | Leverage of 6.3x shareholders’ equity at December 31, 2016 versus 5.8x shareholders’ equity at September 30, 2016 |
• | Dividend declared of $0.21 per common share |
• | Comprehensive income of $0.29 per common share comprised of net income to common shareholders of $0.69 per common share and other comprehensive loss of $(0.40) per common share |
• | Core net operating income, a non-GAAP measure, of $0.83 per common share |
• | Net interest spread of 1.97% and adjusted net interest spread, a non-GAAP measure, of 1.88% |
• | net interest income from investments of $16.1 million versus $15.1 million for the third quarter |
• | gain on derivative instruments, net of $56.5 million versus $2.4 million for the third quarter, and; |
• | an unrealized loss on MBS of $(85.1) million versus an unrealized gain of $0.8 million for the third quarter. |
($ in thousands) | RMBS | CMBS | CMBS IO | Total | |||||||||||
Balance at September 30, 2016 | $ | 1,339,268 | $ | 1,027,976 | $ | 743,223 | $ | 3,110,467 | |||||||
Purchases | — | 278,384 | 59,846 | 338,230 | |||||||||||
Principal payments | (90,541 | ) | (22,691 | ) | — | (113,232 | ) | ||||||||
Sales | — | — | — | — | |||||||||||
Net premium amortization | (4,079 | ) | (1,501 | ) | (32,714 | ) | (38,294 | ) | |||||||
Unrealized loss | (9,881 | ) | (59,397 | ) | (15,809 | ) | (85,087 | ) | |||||||
Balance at December 31, 2016 | $ | 1,234,767 | $ | 1,222,771 | $ | 754,546 | $ | 3,212,084 |
Three Months Ended | |||||||||||||
December 31, 2016 | September 30, 2016 | ||||||||||||
($ in thousands) | Average Balance | Effective Yield | Average Balance | Effective Yield | |||||||||
RMBS | $ | 1,289,139 | 1.84 | % | $ | 1,390,401 | 1.85 | % | |||||
CMBS | 1,115,835 | 3.08 | % | 974,240 | 3.17 | % | |||||||
CMBS IO | 741,577 | 3.92 | % | 724,859 | 3.88 | % | |||||||
MBS effective yield: | $ | 3,146,551 | 2.77 | % | $ | 3,089,500 | 2.75 | % | |||||
Other investments: | 20,047 | 3.78 | % | 21,384 | 3.84 | % | |||||||
Total effective yield: | $ | 3,166,598 | 2.78 | % | $ | 3,110,884 | 2.75 | % |
As of December 31, 2016 | As of September 30, 2016 | |||||||||||||
Collateral Type | Balance | Weighted Average Rate | Balance | Weighted Average Rate | ||||||||||
($ in thousands) | ||||||||||||||
Agency RMBS | $ | 1,157,302 | 0.82 | % | $ | 1,156,635 | 0.70 | % | ||||||
Non-Agency RMBS | 26,149 | 1.98 | % | 38,613 | 1.88 | % | ||||||||
Agency CMBS | 1,005,726 | 0.82 | % | 594,661 | 0.69 | % | ||||||||
Non-Agency CMBS | 66,881 | 1.63 | % | 69,687 | 1.50 | % | ||||||||
Agency CMBS IO | 346,892 | 1.57 | % | 322,632 | 1.38 | % | ||||||||
Non-Agency CMBS IO | 291,199 | 1.67 | % | 290,626 | 1.45 | % | ||||||||
Securitization financing bond | 4,803 | 2.00 | % | 5,424 | 1.86 | % | ||||||||
Total repurchase agreement financing | $ | 2,898,952 | 1.03 | % | $ | 2,478,278 | 0.91 | % | ||||||
FHLB advances collateralized with Agency CMBS | $ | — | — | % | $ | 263,000 | 0.51 | % | ||||||
Three Months Ended December 31, 2016 | Three Months Ended September 30, 2016 | |||||||||||||
Collateral Type | Average Balance | Weighted Average Rate | Average Balance | Weighted Average Rate | ||||||||||
($ in thousands) | ||||||||||||||
Agency RMBS | $ | 1,156,147 | 0.78 | % | $ | 1,218,852 | 0.67 | % | ||||||
Non-Agency RMBS | 29,653 | 1.90 | % | 42,359 | 1.85 | % | ||||||||
Agency CMBS | 884,786 | 0.75 | % | 564,119 | 0.68 | % | ||||||||
Non-Agency CMBS | 68,257 | 1.53 | % | 89,221 | 1.43 | % | ||||||||
Agency CMBS IO | 335,630 | 1.41 | % | 328,644 | 1.34 | % | ||||||||
Non-Agency CMBS IO | 289,266 | 1.49 | % | 287,608 | 1.42 | % | ||||||||
Securitization financing bond | 5,030 | 1.91 | % | 5,760 | 1.84 | % | ||||||||
Total repurchase agreement financing | 2,768,769 | 0.95 | % | 2,536,563 | 0.89 | % | ||||||||
Other financing (1) | 64,101 | 0.59 | % | 270,385 | 0.53 | % | ||||||||
Total average liabilities and cost of funds | $ | 2,832,870 | 0.94 | % | $ | 2,806,948 | 0.85 | % |
Effective Period | Weighted Average Notional Outstanding for the Period (1) | Weighted Average Net Pay Rate (1) | |||||
($ in thousands) | |||||||
2017 | $ | 198,110 | 0.52 | % | |||
2018 | 1,712,466 | 1.79 | % | ||||
2019 | 1,654,164 | 1.83 | % | ||||
2020 | 1,377,391 | 2.11 | % | ||||
2021 | 1,509,726 | 2.26 | % | ||||
2022 | 1,253,425 | 2.52 | % | ||||
2023 | 1,250,000 | 2.52 | % | ||||
2024 | 1,257,104 | 2.52 | % | ||||
2025 | 845,342 | 2.47 | % | ||||
2026 | 491,370 | 2.43 | % |
(1) | Includes pay-fixed interest rate swaps, net of receive-fixed interest rate swaps. |
($ in thousands) | Change in Fair Value of Derivative Instruments | Periodic Interest Costs (1) | Gain (Loss) on Derivative Instruments, Net | ||||||||
Receive-fixed interest rate swaps | $ | (9,848 | ) | $ | 1,063 | $ | (8,785 | ) | |||
Pay-fixed interest rate swaps | 57,807 | (1,202 | ) | 56,605 | |||||||
Eurodollar futures | 8,726 | — | 8,726 | ||||||||
Total | $ | 56,685 | $ | (139 | ) | $ | 56,546 |
(1) | Amounts represent interest earned or incurred related to interest rate swaps effective during the quarter. |
# | # | # |
December 31, 2016 | December 31, 2015 | ||||||
ASSETS | (unaudited) | ||||||
Mortgage-backed securities | $ | 3,212,084 | $ | 3,493,701 | |||
Mortgage loans held for investment, net | 19,036 | 24,145 | |||||
Investment in limited partnership | — | 10,835 | |||||
Investment in FHLB stock | 9 | 11,475 | |||||
Cash and cash equivalents | 74,120 | 33,935 | |||||
Restricted cash | 24,769 | 51,190 | |||||
Derivative assets | 28,534 | 7,835 | |||||
Principal receivable on investments | 11,978 | 6,193 | |||||
Accrued interest receivable | 20,396 | 22,764 | |||||
Other assets, net | 6,805 | 7,975 | |||||
Total assets | $ | 3,397,731 | $ | 3,670,048 | |||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
Liabilities: | |||||||
Repurchase agreements | $ | 2,898,952 | $ | 2,589,420 | |||
FHLB advances | — | 520,000 | |||||
Non-recourse collateralized financing | 6,440 | 8,442 | |||||
Derivative liabilities | 6,922 | 41,205 | |||||
Accrued interest payable | 3,156 | 1,743 | |||||
Accrued dividends payable | 12,268 | 13,709 | |||||
Other liabilities | 2,809 | 3,504 | |||||
Total liabilities | 2,930,547 | 3,178,023 | |||||
Shareholders’ equity: | |||||||
Preferred stock, par value $.01 per share; 50,000,000 shares authorized; 4,571,937 and 4,550,000 shares issued and outstanding, respectively ($114,298 and $113,750 aggregate liquidation preference, respectively) | $ | 110,005 | $ | 109,658 | |||
Common stock, par value $.01 per share, 200,000,000 shares authorized; 49,153,463 and 49,047,335 shares issued and outstanding, respectively | 492 | 490 | |||||
Additional paid-in capital | 727,369 | 725,358 | |||||
Accumulated other comprehensive loss | (32,609 | ) | (12,768 | ) | |||
Accumulated deficit | (338,073 | ) | (330,713 | ) | |||
Total shareholders' equity | 467,184 | 492,025 | |||||
Total liabilities and shareholders’ equity | $ | 3,397,731 | $ | 3,670,048 | |||
Book value per common share | $ | 7.18 | $ | 7.71 |
Three Months Ended | Year Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||
(unaudited) | (unaudited) | (unaudited) | |||||||||||||
Interest income | $ | 22,858 | $ | 25,522 | $ | 91,898 | $ | 100,244 | |||||||
Interest expense | 6,753 | 5,833 | 25,231 | 22,605 | |||||||||||
Net interest income | 16,105 | 19,689 | 66,667 | 77,639 | |||||||||||
Gain (loss) on derivative instruments, net | 56,546 | 17,854 | (5,606 | ) | (43,128 | ) | |||||||||
Loss on sale of investments, net | — | (908 | ) | (4,238 | ) | (978 | ) | ||||||||
Fair value adjustments, net | 17 | (6 | ) | 103 | 69 | ||||||||||
Other (expense) income, net | (18 | ) | 180 | 880 | 610 | ||||||||||
General and administrative expenses: | |||||||||||||||
Compensation and benefits | (1,720 | ) | (2,308 | ) | (7,550 | ) | (9,103 | ) | |||||||
Other general and administrative | (1,869 | ) | (1,970 | ) | (7,157 | ) | (8,565 | ) | |||||||
Net income | 69,061 | 32,531 | 43,099 | 16,544 | |||||||||||
Preferred stock dividends | (2,303 | ) | (2,294 | ) | (9,185 | ) | (9,176 | ) | |||||||
Net income to common shareholders | $ | 66,758 | $ | 30,237 | $ | 33,914 | $ | 7,368 | |||||||
Other comprehensive income: | |||||||||||||||
Change in net unrealized gain on available-for-sale investments | $ | (85,087 | ) | $ | (46,512 | ) | $ | (23,828 | ) | $ | (38,561 | ) | |||
Reclassification adjustment for loss on sale of investments, net | — | 908 | 4,238 | 978 | |||||||||||
Reclassification adjustment for de-designated cash flow hedges | (99 | ) | 727 | (251 | ) | 3,499 | |||||||||
Total other comprehensive loss | (85,186 | ) | (44,877 | ) | (19,841 | ) | (34,084 | ) | |||||||
Comprehensive (loss) income to common shareholders | $ | (18,428 | ) | $ | (14,640 | ) | $ | 14,073 | $ | (26,716 | ) | ||||
Net income per common share-basic and diluted | $ | 1.36 | $ | 0.61 | $ | 0.69 | $ | 0.14 | |||||||
Weighted average common shares | 49,151 | 49,299 | 49,114 | 52,847 |
4Q2016 | 3Q2016 | 2Q2016 | 1Q2016 | 4Q2015 | |||||||||||||||
Net income (loss) per common share | $ | 1.36 | $ | 0.25 | $ | (0.11 | ) | $ | (0.81 | ) | $ | 0.61 | |||||||
Core net operating income per common share (1) | $ | 0.20 | $ | 0.20 | $ | 0.21 | $ | 0.22 | $ | 0.25 | |||||||||
Comprehensive (loss) income per common share | $ | (0.37 | ) | $ | 0.27 | $ | 0.35 | $ | 0.04 | $ | (0.30 | ) | |||||||
Dividends per common share | $ | 0.21 | $ | 0.21 | $ | 0.21 | $ | 0.21 | $ | 0.24 | |||||||||
Book value per common share, end of period | $ | 7.18 | $ | 7.76 | $ | 7.69 | $ | 7.54 | $ | 7.71 | |||||||||
Leverage at period end (2) | 6.3 | x | 5.8 | x | 6.1 | x | 6.4 | x | 6.5 | x | |||||||||
Average interest earning assets | $ | 3,166,598 | $ | 3,110,884 | $ | 3,242,413 | $ | 3,429,875 | $ | 3,598,748 | |||||||||
Average interest bearing liabilities | $ | 2,832,870 | $ | 2,806,948 | $ | 2,916,432 | $ | 3,095,490 | $ | 3,237,574 | |||||||||
Net interest income | $ | 16,105 | $ | 15,067 | $ | 16,716 | $ | 18,779 | $ | 19,689 | |||||||||
Adjusted net interest income (1) | $ | 15,866 | $ | 14,813 | $ | 16,150 | $ | 17,126 | $ | 19,093 | |||||||||
Effective yield by investment type: | |||||||||||||||||||
RMBS | 1.84 | % | 1.85 | % | 1.90 | % | 1.91 | % | 1.91 | % | |||||||||
CMBS | 3.08 | % | 3.17 | % | 3.28 | % | 3.33 | % | 3.19 | % | |||||||||
CMBS IO | 3.92 | % | 3.88 | % | 3.83 | % | 3.85 | % | 3.90 | % | |||||||||
Mortgage loans held for investment | 3.78 | % | 3.84 | % | 3.80 | % | 3.82 | % | 3.96 | % | |||||||||
Effective yield-all investments | 2.78 | % | 2.75 | % | 2.77 | % | 2.78 | % | 2.74 | % | |||||||||
Cost of funds (3) | 0.94 | % | 0.85 | % | 0.83 | % | 0.81 | % | 0.70 | % | |||||||||
Net interest spread | 1.84 | % | 1.90 | % | 1.94 | % | 1.97 | % | 2.04 | % | |||||||||
Adjusted cost of funds (1) | 0.97 | % | 0.88 | % | 0.90 | % | 1.02 | % | 0.78 | % | |||||||||
Adjusted net interest spread (1) | 1.81 | % | 1.87 | % | 1.87 | % | 1.76 | % | 1.96 | % | |||||||||
CPR for Agency RMBS (4) | 19.3 | % | 18.9 | % | 17.4 | % | 13.2 | % | 13.5 | % |
(1) | Non-GAAP financial measures are reconciled in the supplement to this release. |
(2) | Leverage is calculated by dividing total liabilities by total shareholders' equity. |
(3) | Percentages shown are based on annualized interest expense amounts divided by average interest bearing liabilities. |
(4) | Represents the 3-month average constant prepayment rate ("CPR"). |
Three Months Ended | |||||||||||||||||||
December 31, 2016 | September 30, 2016 | June 30, 2016 | March 31, 2016 | December 31, 2015 | |||||||||||||||
GAAP net income (loss) to common shareholders | $ | 66,758 | $ | 12,406 | $ | (5,525 | ) | $ | (39,725 | ) | $ | 30,237 | |||||||
Less: | |||||||||||||||||||
(Accretion) amortization of de-designated cash flow hedges (1) | (99 | ) | (99 | ) | (80 | ) | 27 | 727 | |||||||||||
Change in fair value of derivative instruments, net (2) | (56,686 | ) | (2,564 | ) | 15,811 | 46,584 | (19,177 | ) | |||||||||||
Loss on sale of investments, net | — | — | 297 | 3,941 | 908 | ||||||||||||||
Fair value adjustments, net | (17 | ) | (34 | ) | (28 | ) | (24 | ) | 6 | ||||||||||
Core net operating income to common shareholders | $ | 9,956 | $ | 9,709 | $ | 10,475 | $ | 10,803 | $ | 12,701 | |||||||||
Weighted average common shares | 49,151 | 49,147 | 49,119 | 49,041 | 49,299 | ||||||||||||||
Core net operating income per common share | $ | 0.20 | $ | 0.20 | $ | 0.21 | $ | 0.22 | $ | 0.25 | |||||||||
Year Ended | |||||||||||||||||||
December 31, 2016 | December 31, 2015 | ||||||||||||||||||
GAAP net income to common shareholders | $ | 33,914 | $ | 7,368 | |||||||||||||||
Less: | |||||||||||||||||||
(Accretion) amortization of de-designated cash flow hedges (1) | (251 | ) | 3,499 | ||||||||||||||||
Change in fair value of derivative instruments, net (2) | 3,145 | 37,398 | |||||||||||||||||
Loss on sale of investments, net | 4,238 | 978 | |||||||||||||||||
Fair value adjustments, net | (103 | ) | (69 | ) | |||||||||||||||
Core net operating income to common shareholders | $ | 40,943 | $ | 49,174 | |||||||||||||||
Weighted average common shares | 49,114 | 52,847 | |||||||||||||||||
Core net operating income per common share | $ | 0.83 | $ | 0.93 |
(2) | Amount includes any realized gains (losses) recognized during the period presented and excludes net periodic interest costs of derivative instruments. |
Three Months Ended | ||||||||||||||||||||
December 31, 2016 | September 30, 2016 | June 30, 2016 | ||||||||||||||||||
Amount | Yield/Rate | Amount | Yield/Rate | Amount | Yield/Rate | |||||||||||||||
GAAP interest income | $ | 22,858 | 2.78 | % | $ | 21,135 | 2.75 | % | $ | 22,816 | 2.77 | % | ||||||||
GAAP interest expense/cost of funds | 6,753 | 0.94 | % | 6,068 | 0.85 | % | 6,100 | 0.83 | % | |||||||||||
Net interest income/spread | 16,105 | 1.84 | % | 15,067 | 1.90 | % | 16,716 | 1.94 | % | |||||||||||
GAAP interest expense/cost of funds | $ | 6,753 | 0.94 | % | $ | 6,068 | 0.85 | % | $ | 6,100 | 0.83 | % | ||||||||
Less: accretion of de-designated cash flow hedges (1) | 99 | 0.01 | % | 99 | 0.01 | % | 80 | — | % | |||||||||||
Add: net periodic interest costs of derivative instruments | 140 | 0.02 | % | 155 | 0.02 | % | 486 | 0.07 | % | |||||||||||
Adjusted interest expense/adjusted cost of funds | 6,992 | 0.97 | % | 6,322 | 0.88 | % | 6,666 | 0.90 | % | |||||||||||
Adjusted net interest income/spread | $ | 15,866 | 1.81 | % | $ | 14,813 | 1.87 | % | $ | 16,150 | 1.87 | % | ||||||||
Three Months Ended | ||||||||||||||||||||
March 31, 2016 | December 31, 2015 | |||||||||||||||||||
Amount | Yield/Rate | Amount | Yield/Rate | |||||||||||||||||
GAAP interest income | $ | 25,089 | 2.78 | % | $ | 25,522 | 2.74 | % | ||||||||||||
GAAP interest expense/cost of funds | 6,310 | 0.81 | % | 5,833 | 0.70 | % | ||||||||||||||
Net interest income/spread | 18,779 | 1.97 | % | 19,689 | 2.04 | % | ||||||||||||||
GAAP interest expense/cost of funds | $ | 6,310 | 0.81 | % | $ | 5,833 | 0.70 | % | ||||||||||||
Less: amortization of de-designated cash flow hedges (1) | (27 | ) | — | % | (727 | ) | (0.08 | )% | ||||||||||||
Add: net periodic interest costs of derivative instruments | 1,680 | 0.21 | % | 1,323 | 0.16 | % | ||||||||||||||
Adjusted interest expense/ adjusted cost of funds | 7,963 | 1.02 | % | 6,429 | 0.78 | % | ||||||||||||||
Adjusted net interest income/spread | $ | 17,126 | 1.76 | % | $ | 19,093 | 1.96 | % | ||||||||||||
Year Ended | ||||||||||||||||||||
December 31, 2016 | December 31, 2015 | |||||||||||||||||||
GAAP interest income | $ | 91,898 | 2.82 | % | $ | 100,244 | 2.71 | % | ||||||||||||
GAAP interest expense/cost of funds | 25,231 | 0.85 | % | 22,605 | 0.68 | % | ||||||||||||||
Net interest income/spread | 66,667 | 1.97 | % | 77,639 | 2.03 | % | ||||||||||||||
GAAP interest expense/cost of funds | $ | 25,231 | 0.85 | % | $ | 22,605 | 0.68 | % | ||||||||||||
Less: accretion (amortization) of de-designated cash flow hedges (1) | 251 | 0.01 | % | (3,499 | ) | (0.11 | )% | |||||||||||||
Add: net periodic interest costs of derivative instruments | 2,461 | 0.08 | % | 5,730 | 0.18 | % | ||||||||||||||
Adjusted interest expense/adjusted cost of funds | 27,943 | 0.94 | % | 24,836 | 0.75 | % | ||||||||||||||
Adjusted net interest income/spread | $ | 63,955 | 1.88 | % | $ | 75,408 | 1.96 | % |
(1) | Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion (amortization) of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of the Company's discontinuation of hedge accounting. |